ZA889441B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA889441B
ZA889441B ZA889441A ZA889441A ZA889441B ZA 889441 B ZA889441 B ZA 889441B ZA 889441 A ZA889441 A ZA 889441A ZA 889441 A ZA889441 A ZA 889441A ZA 889441 B ZA889441 B ZA 889441B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
present
esters
cimetidine
bioavailability
Prior art date
Application number
ZA889441A
Other languages
English (en)
Inventor
Eberhard Fritz Gottwald
Fritz Gottwald Eberhard
Hermann Peter Osterwald
Peter Osterwald Hermann
David Mayron
Mayron David
Horst Manfred Machoczek
Manfred Machoczek Horst
Original Assignee
Smithkline Dauelsberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Dauelsberg filed Critical Smithkline Dauelsberg
Publication of ZA889441B publication Critical patent/ZA889441B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA889441A 1987-12-23 1988-12-19 Pharmaceutical compositions ZA889441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730011A GB8730011D0 (en) 1987-12-23 1987-12-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA889441B true ZA889441B (en) 1989-12-27

Family

ID=10628958

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889441A ZA889441B (en) 1987-12-23 1988-12-19 Pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5057319A (da)
EP (1) EP0322048B1 (da)
JP (1) JP2840097B2 (da)
AT (1) ATE77236T1 (da)
AU (1) AU605671B2 (da)
CA (1) CA1313140C (da)
DE (1) DE3872199T2 (da)
DK (1) DK415689D0 (da)
ES (1) ES2042723T3 (da)
GB (1) GB8730011D0 (da)
GR (1) GR3005640T3 (da)
IE (1) IE60966B1 (da)
PT (1) PT89260B (da)
WO (1) WO1989005640A1 (da)
ZA (1) ZA889441B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578322A (en) * 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
AU653423B2 (en) * 1991-05-28 1994-09-29 Mcneil-Ppc, Inc. Chewable drug-delivery composition
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
AU2584092A (en) * 1992-09-03 1994-03-29 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
CA2150119C (en) * 1992-11-30 2005-03-15 Robert C. Cuca Tastemasked pharmaceutical materials
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
JP3601071B2 (ja) * 1994-03-11 2004-12-15 不二製油株式会社 ブルーム防止剤並びにこれを含有するラウリン系油脂及びチョコレート類
AUPN862596A0 (en) * 1996-03-12 1996-04-04 F.H. Faulding & Co. Limited Pharmaceutical compositions
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
RU2184570C2 (ru) * 1997-09-30 2002-07-10 Дайити Фармасьютикал Ко., Лтд. Препараты для орального введения
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2424770A1 (en) 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
JP2010503664A (ja) * 2006-09-15 2010-02-04 エコ・ファーマシューティカルズ・ビー．ブイ． 水不溶性医薬活性物質の舌下、頬若しくは経口投与のための医薬投薬単位
CA2664311C (en) * 2006-09-15 2015-08-18 Echo Pharmaceuticals B.V. Granulate containing a pharmaceutically active substance and method for its manufacture
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN107847506A (zh) 2015-06-22 2018-03-27 来普卡公司 含17‑羟基孕酮酯的口服组合物和相关方法
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
JPS6029682B2 (ja) * 1980-07-11 1985-07-12 山之内製薬株式会社 苦味のない製剤用組成物およびその製造法
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
GB2195891A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
US4786502A (en) * 1986-10-06 1988-11-22 The Procter & Gamble Company Palatable solid pharmaceutical compositions
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
ES2052911T3 (es) * 1988-05-04 1994-07-16 Smith Kline French Lab Tableta masticable.

Also Published As

Publication number Publication date
ES2042723T3 (es) 1993-12-16
JPH02502729A (ja) 1990-08-30
EP0322048A1 (en) 1989-06-28
IE883843L (en) 1989-06-23
DE3872199D1 (de) 1992-07-23
US5057319A (en) 1991-10-15
DK415689A (da) 1989-08-23
WO1989005640A1 (en) 1989-06-29
DE3872199T2 (de) 1992-12-17
IE60966B1 (en) 1994-09-07
EP0322048B1 (en) 1992-06-17
PT89260A (pt) 1989-12-29
AU2915789A (en) 1989-07-19
GB8730011D0 (en) 1988-02-03
AU605671B2 (en) 1991-01-17
PT89260B (pt) 1993-07-30
ATE77236T1 (de) 1992-07-15
DK415689D0 (da) 1989-08-23
GR3005640T3 (da) 1993-06-07
CA1313140C (en) 1993-01-26
JP2840097B2 (ja) 1998-12-24

Similar Documents

Publication Publication Date Title
GB8730011D0 (en) Pharmaceutical compositions
IE881368L (en) Pharmaceutical compositions
CA2158630A1 (en) Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability
EP0103387A3 (en) Long-acting matrix tablet formulations
IT1221012B (it) Polimeri caricati con farmaci con migliorate solubilita' e biodisponibilita',procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
PL299870A1 (en) 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, crystalline hydrate of 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, method of obtaining these compounds, pharmaceutical preparation and method of fighting against bacteriae
JPS56110612A (en) Readily disintegrable and absorbable compression molded article of slightly soluble drug
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
IT8522493A0 (it) Ottenute. procedimento per la preparazione di compresse, anche a rilascio prolungato, di isosorbide-5-mononitrato stabilizzato e formulazioni cosi'
DE68902531T2 (de) Dispergierbare zubereitung.
IT1235053B (it) Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
HUT52374A (en) Process for producing pharmaceutical compositions
IE781032L (en) Pharmaceutical compositions
AU4730689A (en) Microgranulates comprising a saturated fatty acid triglyceride and an active substance, and topical pharmaceutical compositions containing such microgranulates
HUT66238A (en) Bicyclic carboxylic acid derivatives, pharmaceutical compositions contg. them as active agent and process to prepare them
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
GB2021409A (en) Pharmaceutical composition
IE831863L (en) Fatty acid compositions.
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
DE69209916T2 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
EP0351876A3 (en) Composition for potentiating vaccination effect
EP0383481A3 (en) Anesthetic oral compositions
HUT45841A (en) Herbicidal compositions comprising 3-amino-2-cyano-acrylic acid ester derivatives as active ingredient and process for producing the active ingredient